STRATEC Biomedical AG, DE000STRA555

STRATEC Biomedical AG, DE000STRA555

16.02.2017 - 18:25:05

STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Notification of Major Holdings

1. Details of issuer STRATEC Biomedical AG Gewerbestr. 37 75217 Birkenfeld Germany 2. Reason for notification X Acquisition/disposal of shares with voting rights   Acquisition/disposal of instruments   Change of breakdown of voting rights   Other reason: 3. Details of person subject to the notification obligation Name: City and country of registered office: Montanaro Asset Management Limited LondonUnited Kingdom 4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3.  5. Date on which threshold was crossed or reached 10 Feb 2017 6. Total positions   % of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) total of both in % (7.a. + 7.b.) total number of voting rights of issuer Resulting situation 2.93 % 0 % 2.93 % 11860995 Previous notification 4.78 % n/a % n/a % / 7. Notified details of the resulting situation a. Voting rights attached to shares (Sec.s 21, 22 WpHG) ISIN absolute in %   direct (Sec. 21 WpHG) indirect (Sec. 22 WpHG) direct (Sec. 21 WpHG) indirect (Sec. 22 WpHG) DE000STRA555 0 346960 0 % 2.93 % Total 346960 2.93 % b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in % %     Total % b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in % %       Total % 8. Information in relation to the person subject to the notification obligationX Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.).   Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: Name % of voting rights (if at least held 3% or more) % of voting rights through instruments (if at least held 5% or more) Total of both (if at least held 5% or more)   9. In case of proxy voting according to Sec. 22 para. 3 WpHGDate of general meeting: Holding position after general meeting: % (equals voting rights) 10. Other explanatory remarks: 

16.02.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English

Company: STRATEC Biomedical AG Gewerbestr. 37 75217 Birkenfeld

Germany Internet: www.stratec.com   End of News DGAP News Service

545279  16.02.2017 

@ dgap.de

Amazon dreht Ihnen diesen Videokurs für teuer Geld an! Doch wir machen Sie auch KOSTENLOS …

... zum Super-Trader! Ja, während andere Anleger ein Vermögen blechen mussten, um diesen meisterlichen Videokurs von Spitzen-Analyst Dennis Gürtler zu sehen, zahlen Sie jetzt KEINEN CENT! Sichern Sie sich Ihre Teilnahme am Videokurs jetzt und werden auch Sie zum Supertrader!

>> Klicken Sie jetzt HIER, um zum Supertrader zu werden!